查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587458

傳染性呼吸道疾病診斷市場規模、佔有率和趨勢分析：按產品、樣本、應用、技術、最終用途、地區和細分市場預測，2025-2030 年

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product (Instruments, Services, Consumables), By Sample (Blood, NPS), By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

傳染性呼吸道疾病診斷市場的成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球傳染性呼吸道疾病診斷市場預計將達到 735.6 億美元。

預計2025年至2030年該市場將以5.3%的複合年成長率成長。市場規模的下降主要是由於COVID-19檢測的減少。然而，不受 COVID-19 影響的市場預計在預測期內將會成長。這種成長可歸因於傳染性呼吸道疾病的日益普及以及政府和非營利組織推出新的創新產品以滿足不斷成長的需求的舉措。例如，全球結核病研發投資達9.15億美元，美國政府2020年用於結核病研究的支出約為4.01億美元。

在預測期內，全球產業預計將受到結核病、呼吸道合胞病毒和流感等傳染性呼吸道疾病盛行率上升的推動。根據聯合國統計，肺炎每年影響約 420 萬人。大公司正在開發創新技術並提高生產力，以滿足對診斷感染疾病的診斷試劑和耗材不斷成長的需求。例如，Opto Industries 推出了 3D 列印系統 InstaSwab，以解決因 COVID-19 大流行而導致的樣本採集套件供不應求。這種棉籤由編織網格製成，比傳統棉籤吸收和釋放更多液體。該公司正在利用新技術改進其診斷產品，以實現針對特定目標的準確診斷結果。

2021年3月，Canon宣布開發數位X光內建AEC援助。此 X 光影像感測器可實現 X 光相容的影像生成和即時檢測。此外，2021 年 5 月，加州大學開發了一種超靈敏分子測試，利用晶片技術來識別 SARS-CoV-2 和甲型流感抗原的存在。此外，多家公司也提供同時診斷 RSV、流感和 COVID-19 呼吸道疾病的多重檢測。 RT-PCR 檢測被認為是病患診斷 COVID-19 的黃金標準。然而，與分子檢測相關的高價格是抑制該市場的主要因素之一。

缺乏可比產品也是價格上漲的原因。每種分子診斷產品的價格根據其預期用途的不同而存在很大差異，進一步加劇了這個問題。公司正在採取新產品發布和合作夥伴關係等策略來提高傳染性呼吸道疾病診斷產品的滲透率。例如，2021 年 8 月，Thermo Fisher Scientific Inc. 獲得 EUA 向美國市場推出兩款 COVID-19 診斷產品 TaqPath COVID-19 RNase P Combo Kit 和 TaqPath COVID-19 Fast PCR Combo Kit。

傳染病診斷市場報告亮點

  • 消耗品領域佔據市場主導地位，2024 年佔最大收益佔有率，達 64.3%。診斷設備的技術進步導致了更複雜的測試方法和對特殊耗材的需求。
  • 2024 年，COVID-19 細分市場在全球市場佔據主導地位，佔收益的 43.8%。 COVID-19 變體數量的增加、產品核可以及研發的增加推動了這一優勢。
  • 北美傳染性呼吸道疾病診斷市場在全球整體市場中佔據主導地位，2024年佔銷售佔有率的41.85%。
  • 由於政府對診斷藥物開發的關注和研發資金的增加，結核病預計在預測期內將呈現最快的複合年成長率。
  • 由於 IVD 產品滲透率的提高、可支配收入的增加以及低度開發國家的結核病患者病率較高，預計亞太地區將在預測期內經歷最快的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章傳染病診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 傳染病診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章傳染性呼吸道疾病診斷市場：產品評估與趨勢分析

  • 細分儀表板
  • 傳染病診斷市場：波動分析
  • 傳染病診斷市場：展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 裝置
    • 影像檢查
    • 呼吸檢測設備
    • 其他樂器
  • 消耗品
  • 服務

第5章 傳染病診斷市場：樣本估計與趨勢分析

  • 細分儀表板
  • 傳染病診斷市場：波動分析
  • 傳染病診斷市場：展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 唾液
  • 鼻咽拭子
  • 前鼻區
  • 血
  • 其他

第6章 傳染病診斷市場：技術評估與趨勢分析

  • 細分儀表板
  • 傳染病診斷市場：波動分析
  • 傳染病診斷市場：展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 免疫檢測
  • 分子診斷
  • 微生物學
  • 其他技術

第7章傳染性呼吸道疾病診斷市場：應用估算與趨勢分析

  • 細分儀表板
  • 傳染病診斷市場：波動分析
  • 傳染病診斷市場：展望
  • 2018-2030年市場規模、預測及趨勢分析
  • COVID-19
  • 流感
  • 呼吸道融合病毒（RSV）
  • 結核
  • 鏈球菌測試
  • 其他呼吸道疾病測試

第8章傳染性呼吸道疾病診斷市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 傳染病診斷市場：波動分析
  • 傳染病診斷市場：展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 診斷實驗室
  • 製藥和生物技術公司
  • 醫生辦公室
  • 其他最終用戶

第9章傳染性呼吸道疾病診斷市場：區域估計與趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 2024 年企業市場佔有率分析
  • 主要企業簡介
    • ABBOTT
    • F. Hoffmann-La Roche Ltd
    • THERMO FISHER SCIENTIFIC, INC.
    • KONINKLIJKE PHILIPS NV
    • BIOMERIEUX SA
    • BIO-RAD LABORATORIES, INC.
    • QUIDEL CORPORATION
    • CEPHEID
    • QIAGEN
    • SIEMENS HEALTHCARE GMBH
Product Code: GVR-4-68039-976-4

Infectious Respiratory Disease Diagnostics Market Growth & Trends:

The global infectious respiratory disease diagnostics market size is anticipated to reach USD 73.56 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.3% from 2025 to 2030. The decline in market size is majorly attributed to the decline in COVID-19 testing. However, the market without the impact of COVID-19 is expected to grow over the forecast years. The growth can be attributed to an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products to address the increasing demand. For instance, the global investment in tuberculosis R&D reached USD 915 million, and around USD 401 million was spent by the U.S. government on TB research in 2020.

During the forecast period, the global industry is expected to be driven by the rising incidence of infectious respiratory disorders, such as tuberculosis, RSV, and influenza. According to the UN, pneumonia affects around 4.2 million people every year. Key players are developing innovative techniques to improve production for meeting the growing demand in diagnostics and consumables for the diagnosis of infectious diseases. For instance, OPT Industries Inc. has introduced InstaSwab by utilizing the 3D printing system to address supply shortages of sample collection kits due to the COVID-19 pandemic. These swabs are made of woven lattices to absorb and release more fluid than conventional swabs. Companies are advancing their diagnosis products by using new techniques to gain target-specific and accurate results.

Canon Inc. announced the development of a built-in AEC assistance for digital X-rays in March 2021. The X-ray image sensor enables users to perform picture production and real-time detection of images corresponding to emitted X-rays. Furthermore, in May 2021, the University of California developed an ultrasensitive molecular test to identify the presence of SARS-CoV-2 and influenza A antigens using chip technology. In addition, companies are also launching multiplex tests for the simultaneous diagnosis of RSV, influenza, and COVID-19 respiratory diseases. RT-PCR tests are considered the gold standard for the diagnosis of COVID-19 in patients. However, high prices associated with molecular tests are one of the major factors impeding this market.

The lack of comparable products is another reason for hiked prices. This problem is further compounded by the significant variations in prices for different applications of each molecular diagnostic product. Companies are adopting strategies, such as new product launches and partnerships, to increase the penetration of infectious respiratory disease diagnostics products. For instance, in August 2021, Thermo Fisher Scientific Inc. received EUA for the introduction of two COVID-19 diagnostic products, TaqPath COVID-19 RNase P Combo Kit and TaqPath COVID-19 Fast PCR Combo Kit, in the U.S. market.

Infectious Respiratory Disease Diagnostics Market Report Highlights:

  • The consumables segment dominated the market and accounted for the largest revenue share of 64.3% in 2024. Technological advancements in diagnostic devices have resulted in more sophisticated testing methods, necessitating specialized consumables.
  • The COVID-19 segment dominated the global market in 2024, accounting for 43.8% of the revenue. Increased COVID-19 variants, product approvals, and heightened research and development efforts drove this dominance.
  • North America infectious respiratory disease diagnostics market dominated the overall global market and accounted for 41.85% of revenue share in 2024.
  • Tuberculosis is expected to exhibit the fastest CAGR over the forecast period owing to increasing government focus and R&D funding for the development of diagnostics
  • Asia Pacific is expected to experience the fastest growth over the forecast period owing to an increase in penetration of IVD products, rise in disposable income, and high prevalence of tuberculosis in underdeveloped countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Sample
    • 1.2.3. Product
    • 1.2.4. End Use
    • 1.2.5. Application
    • 1.2.6. Regional Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Infectious Respiratory Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High Prevalence Of Infectious Respiratory Diseases Globally
      • 3.2.1.2. Technological Advancement In Respiratory Disease Testing
      • 3.2.1.3. Rising R&D Investments In Respiratory Disease Testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Prices Of Diagnostic Products
      • 3.2.2.2. Presence Of Ambiguous Regulatory Framework
  • 3.3. Infectious Respiratory Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Infectious Respiratory Disease Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infectious Respiratory Disease Diagnostics Market: Product Movement Analysis
  • 4.3. Infectious Respiratory Disease Diagnostics Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Instruments
    • 4.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Imaging Tests
      • 4.5.2.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Respiratory Measurement Devices
      • 4.5.3.1. Respiratory Measurement Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Other Instruments
      • 4.5.4.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Services
    • 4.7.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infectious Respiratory Disease Diagnostics Market: Sample Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infectious Respiratory Disease Diagnostics Market: Sample Movement Analysis
  • 5.3. Infectious Respiratory Disease Diagnostics Market by Sample Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Saliva
    • 5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Nasopharyngeal Swabs
    • 5.6.1. Nasopharyngeal Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Anterior Nasal Region
    • 5.7.1. Anterior Nasal Region Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Blood
    • 5.8.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infectious Respiratory Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
  • 6.3. Infectious Respiratory Disease Diagnostics Market by Technology Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Immunoassay
    • 6.5.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Molecular Diagnostics
    • 6.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Microbiology
    • 6.7.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Other Technologies
    • 6.8.1. Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Infectious Respiratory Disease Diagnostics Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
  • 7.3. Infectious Respiratory Disease Diagnostics Market by Application Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. COVID-19
    • 7.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Influenza
    • 7.6.1. Influenza Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Respiratory Syncytial Virus
    • 7.7.1. Respiratory Syncytial Virus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Tuberculosis
    • 7.8.1. Tuberculosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Streptococcus Testing
    • 7.9.1. Streptococcus Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Other Respiratory Disease Testing
    • 7.10.1. Other Respiratory Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Infectious Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Infectious Respiratory Disease Diagnostics Market: End Use Movement Analysis
  • 8.3. Infectious Respiratory Disease Diagnostics Market by End Use Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Hospitals
    • 8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Diagnostic Laboratories
    • 8.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Pharmaceutical & Biotechnology Companies
    • 8.7.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Physician Offices
    • 8.8.1. Physician Offices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Other End-Users
    • 8.9.1. Other End-Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Infectious Respiratory Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Recent Developments & Impact Analysis by Key Market Participants
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. Key Company Profiles
    • 10.4.1. ABBOTT
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. F. Hoffmann - La Roche Ltd
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. THERMO FISHER SCIENTIFIC, INC.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. KONINKLIJKE PHILIPS N.V.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. BIOMERIEUX SA
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. BIO-RAD LABORATORIES, INC.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. QUIDEL CORPORATION
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. CEPHEID
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. QIAGEN
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. SIEMENS HEALTHCARE GMBH
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 4. Global infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 5. Global infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 6. Global infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 7. Global infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. North America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 9. North America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 10. North America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 11. North America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 12. North America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 14. U.S. infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 15. U.S. infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 16. U.S. infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 17. U.S. infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 18. Canada infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Canada infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 20. Canada infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 21. Canada infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 22. Canada infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 23. Mexico infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 24. Mexico infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 25. Mexico infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 26. Mexico infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 27. Mexico infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 28. Europe infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 29. Europe infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 30. Europe infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 31. Europe infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 32. Europe infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 33. UK infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 34. UK infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 35. UK infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 36. UK infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 37. UK infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 38. Germany infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 39. Germany infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 40. Germany infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 41. Germany infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 42. Germany infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 43. France infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 44. France infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 45. France infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 46. France infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 47. France infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 48. Italy infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 49. Italy infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 50. Italy infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 51. Italy infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 52. Italy infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 53. Spain infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 54. Spain infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 55. Spain infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 56. Spain infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 57. Spain infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Denmark infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 59. Denmark infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 60. Denmark infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 61. Denmark infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 62. Denmark infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 63. Sweden infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 64. Sweden infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 65. Sweden infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Sweden infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 67. Sweden infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 68. Norway infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Norway infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 70. Norway infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 71. Norway infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 72. Norway infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 73. Asia Pacific infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 74. Asia Pacific infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 75. Asia Pacific infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 76. Asia Pacific infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 77. Asia Pacific infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 78. Japan infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 79. Japan infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 80. Japan infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 81. Japan infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 82. Japan infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 83. China infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 84. China infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 85. China infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 86. China infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 87. China infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 88. India infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 89. India infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 90. India infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 91. India infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 92. India infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 93. Australia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 94. Australia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 95. Australia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 96. Australia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 97. Australia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 98. South Korea infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 99. South Korea infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 100. South Korea infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 101. South Korea infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 102. South Korea infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 103. Thailand infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 104. Thailand infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 105. Thailand infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 106. Thailand infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 107. Thailand infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 108. Latin America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 109. Latin America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 110. Latin America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 111. Latin America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 112. Latin America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Brazil infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 114. Brazil infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 115. Brazil infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 116. Brazil infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 117. Brazil infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 118. Argentina infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 119. Argentina infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 120. Argentina infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 121. Argentina infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 122. Argentina infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 123. Middle East & Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 124. Middle East & Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 125. Middle East & Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 126. Middle East & Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 127. Middle East & Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 128. South Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 129. South Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 130. South Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 131. South Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 132. South Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 133. Saudi Arabia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 134. Saudi Arabia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 135. Saudi Arabia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 136. Saudi Arabia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 137. Saudi Arabia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 138. UAE infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 139. UAE infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 140. UAE infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 141. UAE infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 142. UAE infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 143. Kuwait infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 144. Kuwait infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 145. Kuwait infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 146. Kuwait infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 147. Kuwait infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Infectious respiratory disease diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Infectious respiratory disease diagnostics market, Product outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 12 Infectious respiratory disease diagnostics market, Sample outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 13 Infectious respiratory disease diagnostics market, Technology outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 14 Infectious respiratory disease diagnostics market, Application outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 15 Infectious respiratory disease diagnostics market, End Use outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 16 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Imaging Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Respiratory Measurement Devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Other Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Saliva market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Nasopharyngeal Swabs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Anterior Nasal Region market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Blood market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Immunoassay market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Molecular Diagnostics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Microbiology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Other Technologies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 COVID-19 market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Influenza market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Respiratory Syncytial Virus market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Tuberculosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Streptococcus Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Other Respiratory Disease Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diagnostic Laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Physician Offices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Other End users market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 North America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Mexico infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Norway infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 India infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Middle East and Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 UAE infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Kuwait infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 List of key emerging company's/Allergen disruptors/innovators